These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6405755)

  • 1. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
    Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
    Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary report on the clinical application of anti-Jo-1 antibody].
    Dong Y; Cheng PC; Zhang NC
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
    Walker EJ; Tymms KE; Webb J; Jeffrey PD
    J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.
    Fudman EJ; Schnitzer TJ
    Semin Arthritis Rheum; 1986 May; 15(4):255-60. PubMed ID: 3520822
    [No Abstract]   [Full Text] [Related]  

  • 8. Marker antibodies in scleroderma and polymyositis: clinical associations.
    de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ
    Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
    Bernstein RM; Morgan SH; Chapman J; Bunn CC; Mathews MB; Turner-Warwick M; Hughes GR
    Br Med J (Clin Res Ed); 1984 Jul; 289(6438):151-2. PubMed ID: 6430389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis.
    Nash P; Schrieber L; Webb J
    Clin Rheumatol; 1987 Jun; 6(2):282-6. PubMed ID: 3497760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between Mi-2 antibodies and dermatomyositis.
    Targoff IN; Reichlin M
    Arthritis Rheum; 1985 Jul; 28(7):796-803. PubMed ID: 2409985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype.
    Wasicek CA; Reichlin M; Montes M; Raghu G
    Am J Med; 1984 Mar; 76(3):538-44. PubMed ID: 6702878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Aggarwal R; Cassidy E; Fertig N; Koontz DC; Lucas M; Ascherman DP; Oddis CV
    Ann Rheum Dis; 2014 Jan; 73(1):227-32. PubMed ID: 23422076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports].
    Fischer E; Thiele A; Stierle HE; Lang B
    Z Rheumatol; 1995; 54(3):171-7. PubMed ID: 7660688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
    Biswas T; Miller FW; Takagaki Y; Plotz PH
    J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Jo-1 Syndrome--immunological findings and clinical manifestations].
    Seiberlich B; Hunzelmann N; Roers A; Weber M; Schulze-Lohoff E
    Med Klin (Munich); 2005 Mar; 100(3):137-42. PubMed ID: 15966441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Jo-1 antibodies.
    Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
    Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.